Fuji Pharma Co (FRA:FUP) Other Current Receivables: €1.1 Mil (As of Mar. 2026)


FRA:FUP Fuji Pharma Co Ltd FRA:FUP
87 GF Score
Price €10.10
GF Value €9.98
! 3 Warning Signs
View Full Analysis

What is Fuji Pharma Co Other Current Receivables?

Fuji Pharma Co FRA:FUP +2.54% 87 Other Current Receivables is €1.1 Mil as of Mar. 2026. GuruFocus rates FRA:FUP with a GF Score™ of 87/100 and a GF Value™ of €9.98. The stock has 3 warning signs investors should review.

Fuji Pharma Co's Other Current Receivables for the quarter that ended in Mar. 2026 was €1.1 Mil.

Fuji Pharma Co's quarterly Other Current Receivables declined from Sep. 2025 (€1.71 Mil) to Dec. 2025 (€1.33 Mil) but then stayed the same from Dec. 2025 (€1.33 Mil) to Mar. 2026 (€1.05 Mil).

Fuji Pharma Co's annual Other Current Receivables increased from Sep. 2023 (€1.37 Mil) to Sep. 2024 (€2.86 Mil) but then declined from Sep. 2024 (€2.86 Mil) to Sep. 2025 (€1.71 Mil).

Fuji Pharma Co Other Current Receivables Related Terms

Fuji Pharma Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Fuji Pharma Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fuji Pharma Co Other Current Receivables Chart

Fuji Pharma Co Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.91 0.94 1.37 2.86 1.71

Fuji Pharma Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.24 2.80 1.71 1.33 1.05
FRA:FUP
87GF Score
Fuji Pharma Co Ltd FRA:FUP
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fuji Pharma Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of €1.1 Mil mean?
Fuji Pharma Co (FRA:FUP) has a Other Current Receivables of €1.1 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Fuji Pharma Co and its competitors.
Is Fuji Pharma Co's Other Current Receivables too high?
Fuji Pharma Co's current Other Current Receivables is €1.1 Mil. Overall, Fuji Pharma Co has a GF Score™ of 87/100, reflecting its overall financial health beyond just this single metric.
How does Fuji Pharma Co's Other Current Receivables compare to ZTS and UTHR?
Fuji Pharma Co's Other Current Receivables of €1.1 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Fuji Pharma Co and its competitors. Fuji Pharma Co's current Other Current Receivables is €1.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fuji Pharma Co stock overvalued right now?
Fuji Pharma Co (FRA:FUP) has a current Other Current Receivables of €1.1 Mil. The stock's GF Value™ is €9.98, compared to a current price of €10.10 — trading 1.2% above its estimated fair value. The current Other Current Receivables is €1.1 Mil. Fuji Pharma Co's overall GF Score™ is 87/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Fuji Pharma Co (FRA:FUP), the current Other Current Receivables is €1.1 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fuji Pharma Co (FRA:FUP) Overvalued in 2026?

Based on GuruFocus' analysis, Fuji Pharma Co stock appears to be overvalued. The current stock price of €10.10 is trading 1.2% above its estimated GF Value™ of €9.98.

Key valuation signals for FRA:FUP:

  • Other Current Receivables: €1.1 Mil
  • GF Value™: €9.98 vs. price of €10.10 (1.2% above fair value)
  • GF Score™: 87/100 with 3 warning signs

No single metric tells the full story. See the FRA:FUP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fuji Pharma Co Business Description

Other Exchanges 4554:Japan
Address 5-7 Sanban-cho, Chiyoda-ku, Tokyo, JPN, 102-0075
Fuji Pharma Co Ltd is involved in the development, manufacture, and marketing of pharmaceutical products, such as injection agents, internal drugs, drugs for external use, and diagnostic products. The group consists of a single segment, the pharmaceutical business.
87GF Score

Get the complete analysis for FRA:FUP

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.10
Price
€9.98
GF Value